Beranda › Skleroderma › New York › New York City
Uji klinis Skleroderma di New York City, NY
11 studi untuk Skleroderma mencari peserta di lokasi sekitar New York City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Menerima pesertaFase 3
- Hospital for Special Surgery, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center-New York Presbyterian Hospital, New York
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Menerima pesertaFase 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Menerima pesertaFase 1
- Icahn School of Medicine at Mount Sinai, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Menerima pesertaFase 2/3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
Platform Clinical Study for Conquering Scleroderma
Menerima pesertaFase 2
- Hospital for Special Surgery, New York
- Columbia University Medical Center, New York
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Menerima pesertaFase 2/3
- Columbia University Irving Medical Center, New York
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Menerima pesertaFase 1/2
- Nkarta Investigational Site, New York
A Study of AZD0120 in Autoimmune Diseases
Menerima pesertaFase 1
- Research Site, New York
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Menerima pesertaFase 1
- Montefiore Medical Center, New York
Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis
Menerima pesertaFase 2
- Hospital for Special Surgery, New York
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Menerima pesertaFase 2
- aTyr Investigative Site, New York
Uji klinis Skleroderma di kota lain
- Ann Arbor, MI10 studi
- Chicago, IL10 studi
- Houston, TX9 studi
- Boston, MA7 studi
- Durham, NC7 studi
- Los Angeles, CA7 studi
- New Orleans, LA6 studi
- Philadelphia, PA6 studi
- Baltimore, MD6 studi
- Dallas, TX5 studi
- Pittsburgh, PA5 studi
- Plantation, FL4 studi
Studi lain di New York City
- Kanker Payudara134 studi
- Kanker Paru Non-Sel Kecil120 studi
- Kanker (semua jenis)110 studi
- Kanker Prostat103 studi
- Kanker Metastatik93 studi
- Kanker Kolorektal77 studi
- Kanker Ovarium69 studi
- Kanker Paru60 studi
- Kanker Pankreas60 studi
- Mieloma Multipel60 studi
- Kanker Endometrium52 studi
- Gagal Jantung51 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.